Rethinking the Relationship between Insulin and Cancer.

Abstract

In addition to being a major metabolic hormone, insulin is also a growth factor with a mitogenic effect on all cells, more marked in malignant cells that often overexpress the insulin receptor. In patients with metabolic diseases characterized by hyperinsulinemia (obesity, type 2 diabetes, and metabolic syndrome), the incidence of several types of cancer is increased, as is cancer-related mortality. Because of the worldwide growing prevalence of metabolic diseases and the diffuse use of insulin and its analogs for treating diabetes, the relationship between insulin and cancer has become a clinically relevant issue. Clinical studies have not clarified the degree to which hyperinsulinemia can influence cancer occurrence and prognosis. To better understand this issue, an improved scientific approach is required, with more careful consideration of the mechanisms related to hyperinsulinemia and carcinogenesis.

• Authors: R Vigneri, L Sciacca, P Vigneri
• Journal: Trends in endocrinology and metabolism: TEM (Trends Endocrinol Metab) Vol. 31 Issue 8 Pg. 551-560 (08 2020) ISSN: 1879-3061 [Electronic] United States
• PMID: 32600959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2020 Elsevier Ltd. All rights reserved.

Chemical References

• Insulin

Topics

• Animals
• Diabetes Mellitus, Type 2 (physiopathology)
• Humans
• Hyperinsulinism (metabolism)
• Insulin (metabolism)
• Insulin Resistance (physiology)
• Neoplasms (metabolism)
• Obesity (metabolism)